Cargando…
Osteogenic commitment of Wharton’s jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application
BACKGROUND: Orthopaedic diseases are one of the major targets for regenerative medicine. In this context, Wharton’s jelly (WJ) is an alternative source to bone marrow (BM) for allogeneic transplantation since its isolation does not require an invasive procedure for cell collection and does not raise...
Autores principales: | Cabrera-Pérez, Raquel, Monguió-Tortajada, Marta, Gámez-Valero, Ana, Rojas-Márquez, Raquel, Borràs, Francesc Enric, Roura, Santiago, Vives, Joaquim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883559/ https://www.ncbi.nlm.nih.gov/pubmed/31779673 http://dx.doi.org/10.1186/s13287-019-1450-3 |
Ejemplares similares
-
Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View
por: Muñoz-Domínguez, Noelia, et al.
Publicado: (2021) -
Human Wharton’s jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment
por: Cabrera-Pérez, Raquel, et al.
Publicado: (2023) -
The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021) -
Osteogenic differentiation of mesenchymal stem cells cultured on PLLA scaffold coated with Wharton's Jelly
por: Ahmadi, Marziehsadat, et al.
Publicado: (2017) -
Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance
por: Vives, Joaquim, et al.
Publicado: (2022)